e-learning
resources
Berlin 2008
Monday, 06.10.2008
Aetiology of respiratory infections: mycobacteria and fungi
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The effect of clarithromycin on immunity of mice with chronic respiratory infection caused by
P. aeruginosa
R. Shirai, C. Moser, P. Jensen, K. Kishi, H. Calum, H. Ishii, I. Tokimatsu, K. Hiramatsu, N. Hoiby, J. I. Kadota (Yufu/Oita, Japan; Copenhagen, Denmark)
Source:
Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi
Session:
Aetiology of respiratory infections: mycobacteria and fungi
Session type:
Thematic Poster Session
Number:
2277
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Shirai, C. Moser, P. Jensen, K. Kishi, H. Calum, H. Ishii, I. Tokimatsu, K. Hiramatsu, N. Hoiby, J. I. Kadota (Yufu/Oita, Japan; Copenhagen, Denmark). The effect of clarithromycin on immunity of mice with chronic respiratory infection caused by
P. aeruginosa
. Eur Respir J 2008; 32: Suppl. 52, 2277
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
The effect of erythromycin on the chronic lower airway infection by pseudomonas aeruginosa
Source: Eur Respir J 2004; 24: Suppl. 48, 640s
Year: 2004
Effect of anti-PcrV antibody in a murine chronic airway Pseudomonas aeruginosa infection model
Source: Eur Respir J 2007; 29: 965-968
Year: 2007
Long term treatment with azithromycin in chronic respiratory infections with
pseudomonas aeruginosa
Source: Eur Respir J 2006; 28: Suppl. 50, 558s
Year: 2006
Dysregulation of systemic and local immune response in cystic fibrosis patients with chronic
P. aeruginosa
infection
Source: Eur Respir J 2004; 24: Suppl. 48, 385s
Year: 2004
Effects of direct lung dosing of Tobramycin in a rat chronic infection model using Pseudomonas aeruginosa RP73
Source: International Congress 2018 – Mechanisms of respiratory infection
Year: 2018
Azithromycin in chronic respiratory infections with
pseudomonas aeruginosa
in patients without cystic fibrosis
Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host
Year: 2008
PcrV antibody prophylaxis in combination with antibiotic therapy reduces lung injury and improves survival in pseudomonas aeruginosa infected mice
Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections
Year: 2011
Impact of
Pseudomonas aeruginosa
infection on Na
+
transport in airway epithelia
Source: Annual Congress 2007 - The impact of viral and bacterial infection on the respiratory epithelium
Year: 2007
LSC Abstract – The host genetic background impacts on pseudomonas aeruginosa-induced T cell responses and individual susceptibility/resistance to respiratory infection
Source: International Congress 2015 – Respiratory infections: from basic science to clinical issues
Year: 2015
Comparison between two protocols of preventing treatment of chronic
Pseudomonas aeruginosa
(
Pa
) infection
Source: Eur Respir J 2005; 26: Suppl. 49, 620s
Year: 2005
Efficacy of low-dose, long-term clarithromycin administration in improving the clinical course in cystic fibrosis patients with chronic
P. aeruginosa
airway colonization
Source: Eur Respir J 2003; 22: Suppl. 45, 514s
Year: 2003
Predicting the outcome of respiratory Pseudomonas aeruginosa infection in vivo
Source: International Congress 2017 – Cystic fibrosis: treatments and monitoring
Year: 2017
In vivo
evidence for aspergillus fumigatus and pseudomonas aeruginosa driven th-17 type inflammatory responses in the lungs of CF-patients
Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease
Year: 2009
The efficacy of early eradication therapy in prevention of chronic
pseudomonas aeruginosa
infection in cystic fibrosis
Source: Eur Respir J 2006; 28: Suppl. 50, 486s
Year: 2006
Antibiotics reduce dual pathogen isolates more than single pathogen isolates following COPD exacerbation
Source: Annual Congress 2009 - Exacerbations of COPD: new findings
Year: 2009
Exploring the susceptibility of P. aeruginosa biofilms in human mucus towards tobramycin treatment
Source: International Congress 2017 – Cystic fibrosis: clinical issues
Year: 2017
Azithromycin protects bronchial epithelial integrity after
Pseudomonas aeruginosa
infection independent of bactericidal activity
Source: Annual Congress 2008 - Best of lung epithelial cells 2008
Year: 2008
Pseudomonas aeruginosa infections
Source: Respipedia Article
Year: 2018
Inhaled phage therapy for the treatment of acute Pseudomonas aeruginosa lung infections
Source: International Congress 2018 – Mechanisms of respiratory infection
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept